Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
767.00    -16.50 (-2.11%)
Bid:
769.50
Ask:
772.50
Spread: 3.00 (0.39%)
Market Cap: £883.38m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

12 Apr 2017 07:00

RNS Number : 2464C
Kainos Group plc
12 April 2017
 

12 April 2017

 

Kainos Group plc

 

("Kainos" or "the Company")

 

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2017.

 

Trading in the year ended 31 March 2017 has continued to be in line with market expectations; the Company has experienced good growth across all divisions, and remains well positioned in its core markets.

 

The increasing trends towards digitisation and adoption of enterprise Software as a Service (SaaS) solutions have continued to generate strong demand for the Company's Digital Services in both public and commercial markets in the UK and Europe.

 

Growth in Digital Platforms remains solid, supported by sustained momentum of Kainos WorkSmart contract wins, although limited funding in the UK's NHS continues to moderate short term growth of Kainos Evolve platforms. The Company continues to invest in development, sales and marketing of its Evolve Integrated Care platform.

 

Kainos has a robust balance sheet with no debt and strong cash generation. The business has a solid pipeline, which includes a growing level of recurring revenue. Recruitment remains strong, with over 216 people joining Kainos since 1 April 2016, bringing the total number of employees and contractors worldwide to 975 at the end of March 2017.

 

The announcement of Kainos results for the year ended 31 March 2017 will be made on Tuesday 30 May 2017.

 

- ENDS -

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Dominic Emery

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Nicola Krafft

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,000 staff and contractors across eight offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIBMFTMBMBBJR
Date   Source Headline
19th Aug 201912:02 pmRNSPrice Monitoring Extension
2nd Aug 20194:52 pmRNSHolding(s) in Company
1st Aug 20192:35 pmRNSTotal Voting Rights
31st Jul 201911:30 amRNSAnnual Report 2019
26th Jul 201911:36 amRNSHolding(s) in Company
24th Jul 20197:00 amRNSBoard Change
18th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20191:24 pmRNSDirector/PDMR Shareholding
4th Jul 20193:10 pmRNSHolding(s) in Company
1st Jul 20192:09 pmRNSTotal Voting Rights
25th Jun 20198:33 amRNSHolding(s) in Company
24th Jun 20191:43 pmRNSHolding(s) in Company
17th Jun 20194:40 pmRNSHolding(s) in Company
17th Jun 20194:26 pmRNSDirector/PDMR Shareholding
31st May 20194:06 pmRNSTotal Voting Rights
29th May 20197:55 amRNSHolding(s) in Company
29th May 20197:44 amRNSHolding(s) in Company
28th May 20197:00 amRNSPreliminary Results
1st May 20196:10 pmRNSTotal Voting Rights
1st May 20196:10 pmRNSBlock listing Interim Review
16th Apr 20197:00 amRNSTrading Statement
1st Apr 20193:29 pmRNSTotal Voting Rights
21st Mar 20194:28 pmRNSHolding(s) in Company
7th Mar 201911:31 amRNSDirector/PDMR Shareholding
28th Feb 201912:11 pmRNSTotal Voting Rights
25th Feb 20194:47 pmRNSHolding(s) in Company
12th Feb 20197:00 amRNSKainos announces site purchase for new Belfast HQ
6th Feb 20195:11 pmRNSAdmission of Shares to Trading
6th Feb 20193:59 pmRNSHolding(s) in Company
5th Feb 20194:01 pmRNSHolding(s) in Company
4th Feb 20194:11 pmRNSTotal Voting Rights
4th Feb 20197:00 amRNSTrading Update
6th Dec 20184:35 pmRNSPrice Monitoring Extension
5th Dec 20181:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20181:38 pmRNSTotal Voting Rights
26th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSInterim Results
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20185:02 pmRNSHolding(s) in Company
1st Nov 20183:57 pmRNSAdmission of Shares to Trading
1st Nov 20183:53 pmRNSBlock Admission
1st Nov 20183:49 pmRNSTotal Voting Rights
18th Oct 201812:07 pmRNSSecond Price Monitoring Extn
18th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20187:00 amRNSChange of Registered Office
1st Oct 20184:47 pmRNSTotal Voting Rights
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.